184 related articles for article (PubMed ID: 26244653)
1. Questions of Safety and Fairness Raised as Right-to-Try Movement Gains Steam.
Jacob JA
JAMA; 2015 Aug; 314(8):758-60. PubMed ID: 26244653
[No Abstract] [Full Text] [Related]
2. Patient advocacy. 'Right to Try' laws bypass FDA for last-ditch treatments.
Servick K
Science; 2014 Jun; 344(6190):1329. PubMed ID: 24948714
[No Abstract] [Full Text] [Related]
3. The strange allure of state "right-to-try" laws.
Zettler PJ; Greely HT
JAMA Intern Med; 2014 Dec; 174(12):1885-6. PubMed ID: 25264589
[No Abstract] [Full Text] [Related]
4. "Right to Try" laws.
Begg CB; Kim K; Neaton JD
Clin Trials; 2014 Oct; 11(5):519-20. PubMed ID: 25190026
[No Abstract] [Full Text] [Related]
5. On Patient Safety: A Right to Try, Not Exploit.
Rickert J
Clin Orthop Relat Res; 2021 Jul; 479(7):1435-1437. PubMed ID: 34086009
[No Abstract] [Full Text] [Related]
6. Expanded Access to Investigational Drugs: What Physicians and the Public Need to Know about FDA and Corporate Processes.
Finkelstein PE
AMA J Ethics; 2015 Dec; 17(12):1142-6. PubMed ID: 26698587
[No Abstract] [Full Text] [Related]
7. The Federal Right to Try Act of 2017-A Wrong Turn for Access to Investigational Drugs and the Path Forward.
Bateman-House A; Robertson CT
JAMA Intern Med; 2018 Mar; 178(3):321-322. PubMed ID: 29356821
[No Abstract] [Full Text] [Related]
8. The Right to Try: An Overview of Efforts to Obtain Expedited Access to Unapproved Treatment for the Terminally Ill.
Tsakopoulos A; Han J; Nodler H; Russo V
Food Drug Law J; 2015; 70(4):617-41. PubMed ID: 26827394
[No Abstract] [Full Text] [Related]
9. Minnesota's Right to Try law.
Hermer LD
Minn Med; 2016; 99(1):30-2. PubMed ID: 26897894
[No Abstract] [Full Text] [Related]
10. Food and Drug Administration responds to pressure for expanded drug access.
Brower V
J Natl Cancer Inst; 2014 Jun; 106(6):dju171. PubMed ID: 24907387
[No Abstract] [Full Text] [Related]
11. Dilemmas in the compassionate supply of investigational cancer drugs.
Lewis JR; Lipworth W; Kerridge I; Doran E
Intern Med J; 2014 Sep; 44(9):841-5. PubMed ID: 25201421
[TBL] [Abstract][Full Text] [Related]
12. Right to try?
Lieu CH; Sorkin A; Messersmith WA
J Clin Oncol; 2015 May; 33(13):1518. PubMed ID: 25779561
[No Abstract] [Full Text] [Related]
13. Right to experimental treatment: FDA new drug approval, constitutional rights, and the public's health.
Leonard EW
J Law Med Ethics; 2009; 37(2):269-79. PubMed ID: 19493072
[TBL] [Abstract][Full Text] [Related]
14. Experts critical of America's right-to-try drug laws.
Rubin R
Lancet; 2015 Oct; 386(10001):1325-6. PubMed ID: 26460764
[No Abstract] [Full Text] [Related]
15. One Last Shot.
Berlin J
Tex Med; 2016 Jul; 112(7):33-8. PubMed ID: 27441422
[TBL] [Abstract][Full Text] [Related]
16. Promoting Patient Interests in Implementing the Federal Right to Try Act.
Lynch HF; Zettler PJ; Sarpatwari A
JAMA; 2018 Sep; 320(9):869-870. PubMed ID: 30105394
[No Abstract] [Full Text] [Related]
17. Right-to-try laws and individual patient "compassionate use" of experimental oncology medications: A call for improved provider-patient communication.
Hoerger M
Death Stud; 2016; 40(2):113-20. PubMed ID: 26313583
[TBL] [Abstract][Full Text] [Related]
18. Access to Investigational Drugs: FDA Expanded Access Programs or "Right-to-Try" Legislation?
Holbein ME; Berglund JP; Weatherwax K; Gerber DE; Adamo JE
Clin Transl Sci; 2015 Oct; 8(5):526-32. PubMed ID: 25588691
[TBL] [Abstract][Full Text] [Related]
19. Fairer way to distribute last-ditch drugs gets real-world trial.
Reardon S
Nature; 2016 Jun; 534(7606):160-1. PubMed ID: 27279187
[No Abstract] [Full Text] [Related]
20. The Ethical Challenges of Compassionate Use.
Caplan AL; Ray A
JAMA; 2016 Mar; 315(10):979-80. PubMed ID: 26868205
[No Abstract] [Full Text] [Related]
[Next] [New Search]